GSK agrees to buy respiratory medicine specialist Aiolos Bio for $1.4bn Date Tuesday, January 09, 2024 - 1:51 AM Description UK pharma group hopes acquisition of three-month start-up will broaden its range of asthma treatments
GSK on hunt for drug deals in China Date Saturday, December 16, 2023 - 10:05 PM Description UK pharma group says country’s chemistry prowess makes it a good source of molecules
GSK reaches $2.2bn heartburn medication Zantac settlement in US Date Wednesday, October 09, 2024 - 11:28 AM Description Move will help resolve concerns hanging over the UK drugmaker
GSK refuses to join Ireland’s mother and baby home compensation scheme Image Date Sunday, January 28, 2024 - 5:57 AM Description Forerunners of pharma company tested vaccines at notorious institutions for decades
GSK sells off remaining stake in Haleon Date Thursday, May 16, 2024 - 11:59 AM Description The sale of its 4.2 per cent holding is expected to raise around £1bn
GSK set to face jury trials over heartburn drug Zantac Date Saturday, June 01, 2024 - 8:39 AM Description Judge rules experts’ evidence admissible, leaving route open for 72,000 cancer sufferers to bring cases
GSK shares jump after drugmaker reaches $2.2bn Zantac settlement Date Thursday, October 10, 2024 - 11:16 AM Description Agreement over heartburn medicine should help to resolve concerns hanging over UK drugmaker
GSK struggles to convince market it can deliver on pipeline plans Date Saturday, February 22, 2025 - 6:00 AM Description US hedge fund shorts drugmaker as shares trade below price of a decade ago
GSK’s new RSV jab set to achieve blockbuster status Date Sunday, January 28, 2024 - 10:00 PM Description Strong uptake of UK pharma group’s vaccine has helped to ease fears of a patent cliff
GSK’s old foe, uncertainty, comes back to haunt it Date Monday, June 03, 2024 - 7:42 AM Description Litigation over Zantac is only one of several doubts the UK pharma group needs to overcome